摘要
乳腺癌术后辅助化疗患者的焦虑和抑郁的发生率高,且对生活质量、治疗依从性等产生不良影响。近年来,随着人们对生活质量重视程度的提高、生物-心理-社会医学模式的应用以及姑息治疗研究的深入开展,医务工作者和相关研究人员不仅关注生存时间、疾病复发,同时关注心理、灵性的痛苦等。国内外亦有研究显示多种心理干预方式均能够一定程度地缓解焦虑及抑郁。本文从乳腺癌术后辅助化疗患者焦虑抑郁的流行病学情况、不良影响、相关因素和干预措施等方面作一简要综述,旨在为该群体患者缓解不良情绪、进行心理干预筛查等提供参考并为深入开展相关工作奠定基础。
The incidence of anxiety and depression in breast cancer patients under postoperative adjuvant chemotherapy is high,and they have adverse effects on the quality of life,therapeutic compliance,and etc.In recent years,with the improvement of people’s attention to quality of life,the application of bio-psycho-social medical model and the further development of palliative treatment research,medical workers and relevant researchers not only pay attention to survival time and disease recurrence,but also to psychological and spiritual pain.Meanwhile,studies at home and abroad have shown that a variety of psychological intervention methods can alleviate anxiety and depression to a certain extent.This article reviews the epidemiology,adverse effects,related factors and intervention measures of anxiety and depression in these breast cancer patients.The purpose of this study is to provide information for alleviating the negative emotion and screening for psychological intervention,and to lay the foundation for further development of the related research.
作者
杨敏
兰波
马飞
蔡建强
徐兵河
YANG Min;LAN Bo;MA Fei;CAI Jianqiang;XU Binghe(National Cancer Center,National Clinical Research Center for Cancer,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)
出处
《临床肿瘤学杂志》
CAS
北大核心
2019年第8期757-761,共5页
Chinese Clinical Oncology
关键词
乳腺癌
辅助化疗
焦虑
抑郁
Breast cancer
Adjuvant chemotherapy
Anxiety
Depression
